Precision adjuvants for pediatric vaccines.

Science translational medicine
Authors
Abstract

Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in pediatric vaccine design. A better understanding of age-specific adjuvants will inform precision discovery and development of safe and effective vaccines for protecting children from preventable infectious diseases.

Year of Publication
2024
Journal
Science translational medicine
Volume
16
Issue
763
Pages
eabq7378
Date Published
09/2024
ISSN
1946-6242
DOI
10.1126/scitranslmed.abq7378
PubMed ID
39231242
Links